Response to second-line taxane-based therapy after first-line epothilone B analogue BMS-247550 (BMS) therapy in hormone refractory prostate cancer (HRPC) Meeting Abstract

  

Authors:	Rosenberg, J. E.; Galsky, M. D.; Weinberg, V.; Kelly, W. K.; Small, E. J.
Abstract Title:	Response to second-line taxane-based therapy after first-line epothilone B analogue BMS-247550 (BMS) therapy in hormone refractory prostate cancer (HRPC)
Meeting Title:	40th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	22
Issue:	14 Suppl.
Meeting Dates:	2004 Jun 5-8
Meeting Location:	New Orleans, LA
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2004-07-15
Start Page:	397S
Language:	English
ACCESSION:	WOS:000223512401576
PROVIDER:	wos
DOI:	10.1200/jco.2004.22.90140.4564
Notes:	Meeting Abstract: 4564 -- 40th Annual Meeting of the American-Society-of-Clinical-Oncology -- JUN 05-08, 2004 -- New Orleans, LA -- S -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/57674